IHEvsPPH
iShares U.S. Pharmaceuticals ETF against VanEck Pharmaceutical ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IHE | PPH | |
|---|---|---|
| Expense ratio | 0.37% | 0.36% |
| Assets | $1.7B | $1.1B |
| Net flow, 1 month | +$49M | −$116M |
| Net flow, 1 year | +$722M | −$250M |
| Return, YTD | +29.2% | +17.9% |
| Return, 1 year | — | — |
| Avg daily volume | 270K | 388K |
| Holdings | 52 | 26 |
| Listed | May 1, 2006 | Feb 1, 2000 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS